insights_auto
Why is REGN34 down 3.24%?
Dive Deeperchevron_right
REGN34:BVMF
Regeneron Pharmaceuticals Inc BDR
R$66.92
arrow_downward
-3.24%(-2.24) 1D
Oct 23, 4:56:00 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN34...
Open
R$67.77
High
R$67.77
Low
R$66.85
Mkt. cap
82.88B
Avg. vol.
695.00
Volume
8.84K
52-wk high
R$73.13
52-wk low
R$49.91
Shares outstanding
101.14M
No. of employees
15K
Open
R$67.77
High
R$67.77
Low
R$66.85
Mkt. cap
82.88B
Avg. vol.
695.00
Volume
8.84K
52-wk high
R$73.13
52-wk low
R$49.91
Shares outstanding
101.14M
No. of employees
15K
News stories
From web sources and news partners
Investing.com
·
6 hours ago
Regeneron stock may move 4.4% on Oct. 30 earnings report
Yahoo Finance
·
8 hours ago
Regeneron (REGN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc BDR
CEOLeonard Schleifer
Employees15.3K
Founded1988
HeadquartersTarrytown, New York, United States
SectorBiotechnology
Websiteregeneron.com